Toth Financial Advisory’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Toth Financial Advisory’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-501	Closed	-$10.7K	–	800
2024 Q1	$10.7K	Buy	+501	New	+$5.99K	﹤0.01%	450

Toth Financial Advisory's FUSN Position: Q2 2024 in Review

Toth Financial Advisory sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 501 shares — an estimated $10.7K sold.

Toth Financial Advisory first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $10.7K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Toth Financial Advisory reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Toth Financial Advisory sold 501 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $10.7K.
Toth Financial Advisory first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Toth Financial Advisory's Fusion Pharmaceuticals Inc. Common Shares position peaked at $10.7K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Toth Financial Advisory's 13F filing for Q2 2024, filed 16 Jul 2024.